Pharvaris Statistics
 Total Valuation
 Pharvaris has a market cap or net worth of $1.61 billion. The enterprise value is $1.37 billion.
 Important Dates
 The next estimated earnings date is Wednesday, November 12, 2025, after market close.
 | Earnings Date | Nov 12, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
 Pharvaris has 72.31 million shares outstanding. The number of shares has increased by 12.81% in one year.
 | Current Share Class | 72.31M | 
| Shares Outstanding | 72.31M | 
| Shares Change (YoY) | +12.81% | 
| Shares Change (QoQ) | +0.37% | 
| Owned by Insiders (%) | 4.71% | 
| Owned by Institutions (%) | 39.91% | 
| Float | 49.02M | 
Valuation Ratios
  | PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| Forward PS | n/a | 
| PB Ratio | 5.62 | 
| P/TBV Ratio | 7.43 | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
 Financial Ratio HistoryEnterprise Valuation
  | EV / Earnings | n/a | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
 The company has a current ratio of 8.33, with a Debt / Equity ratio of 0.00.
 | Current Ratio | 8.33 | 
| Quick Ratio | 8.09 | 
| Debt / Equity | 0.00 | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | n/a | 
Financial Efficiency
 Return on equity (ROE) is -65.09% and return on invested capital (ROIC) is -39.96%.
 | Return on Equity (ROE) | -65.09% | 
| Return on Assets (ROA) | -36.84% | 
| Return on Invested Capital (ROIC) | -39.96% | 
| Return on Capital Employed (ROCE) | -89.58% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | -$1.83M | 
| Employee Count | 108 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
 In the past 12 months, Pharvaris has paid $2.32 million in taxes.
 | Income Tax | 2.32M | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
 The stock price has decreased by -6.36% in the last 52 weeks. The beta is -2.77, so Pharvaris's price volatility has been lower than the market average.
 | Beta (5Y) | -2.77 | 
| 52-Week Price Change | -6.36% | 
| 50-Day Moving Average | 23.20 | 
| 200-Day Moving Average | 18.93 | 
| Relative Strength Index (RSI) | 45.58 | 
| Average Volume (20 Days) | 217,798 | 
Short Selling Information
 The latest short interest is 544,623, so 0.75% of the outstanding shares have been sold short.
 | Short Interest | 544,623 | 
| Short Previous Month | 540,659 | 
| Short % of Shares Out | 0.75% | 
| Short % of Float | 1.11% | 
| Short Ratio (days to cover) | 2.15 | 
Income Statement
  | Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -194.43M | 
| Pretax Income | -195.32M | 
| Net Income | -197.64M | 
| EBITDA | -194.37M | 
| EBIT | -194.43M | 
| Earnings Per Share (EPS) | -$3.63 | 
 Full Income StatementBalance Sheet
 The company has $234.38 million in cash and $744,745 in debt, giving a net cash position of $233.63 million or $3.23 per share.
 | Cash & Cash Equivalents | 234.38M | 
| Total Debt | 744,745 | 
| Net Cash | 233.63M | 
| Net Cash Per Share | $3.23 | 
| Equity (Book Value) | 216.48M | 
| Book Value Per Share | 3.95 | 
| Working Capital | 215.12M | 
 Full Balance SheetCash Flow
 In the last 12 months, operating cash flow was -$160.50 million and capital expenditures -$718,272, giving a free cash flow of -$158.85 million.
 | Operating Cash Flow | -160.50M | 
| Capital Expenditures | -718,272 | 
| Free Cash Flow | -158.85M | 
| FCF Per Share | -$2.20 | 
 Full Cash Flow StatementMargins
  | Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
 Pharvaris does not appear to pay any dividends at this time.
 | Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -12.81% | 
| Shareholder Yield | -12.81% | 
| Earnings Yield | -12.29% | 
| FCF Yield | -9.88% | 
 Analyst Forecast
 The average price target for Pharvaris is $36.50, which is 64.12% higher than the current price. The consensus rating is "Buy".
 | Price Target | $36.50 | 
| Price Target Difference | 64.12% | 
| Analyst Consensus | Buy | 
| Analyst Count | 6 | 
| Revenue Growth Forecast (5Y) | n/a | 
| EPS Growth Forecast (5Y) | n/a | 
 Stock ForecastsFair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
 This stock does not have any record of stock splits.
 | Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
  | Altman Z-Score | n/a | 
| Piotroski F-Score | 1 |